| pubmed-article:21725750 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0262469 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0520997 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0020431 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:21725750 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
| pubmed-article:21725750 | pubmed:dateCreated | 2011-7-4 | lld:pubmed |
| pubmed-article:21725750 | pubmed:abstractText | The only causal therapy in ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (rtPA), but it is feasible only for few patients, and new therapies are needed. This study investigates the effects of systemic thrombolysis with rtPA combined with hyperbaric oxygen therapy (HBOT) in embolic stroke in rats. | lld:pubmed |
| pubmed-article:21725750 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21725750 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21725750 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21725750 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21725750 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21725750 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21725750 | pubmed:issn | 0065-1419 | lld:pubmed |
| pubmed-article:21725750 | pubmed:author | pubmed-author:ZhangJohn HJH | lld:pubmed |
| pubmed-article:21725750 | pubmed:author | pubmed-author:WagnerArminA | lld:pubmed |
| pubmed-article:21725750 | pubmed:author | pubmed-author:SchneiderDiet... | lld:pubmed |
| pubmed-article:21725750 | pubmed:author | pubmed-author:HobohmCarsten... | lld:pubmed |
| pubmed-article:21725750 | pubmed:author | pubmed-author:Küppers-Tiedt... | lld:pubmed |
| pubmed-article:21725750 | pubmed:author | pubmed-author:MichalskiDomi... | lld:pubmed |
| pubmed-article:21725750 | pubmed:author | pubmed-author:GuentherAlbre... | lld:pubmed |
| pubmed-article:21725750 | pubmed:author | pubmed-author:ManaenkoAnato... | lld:pubmed |
| pubmed-article:21725750 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21725750 | pubmed:volume | 111 | lld:pubmed |
| pubmed-article:21725750 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21725750 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21725750 | pubmed:pagination | 167-72 | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:meshHeading | pubmed-meshheading:21725750... | lld:pubmed |
| pubmed-article:21725750 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21725750 | pubmed:articleTitle | Combined systemic thrombolysis with alteplase and early hyperbaric oxygen therapy in experimental embolic stroke in rats: relationship to functional outcome and reduction of structural damage. | lld:pubmed |
| pubmed-article:21725750 | pubmed:affiliation | Department of Neurology, University of Leipzig, Liebigstraße 20, 04103, Leipzig, Germany. kueppers-tiedt@gmx.de | lld:pubmed |
| pubmed-article:21725750 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21725750 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
